Ginn SL, Curtin JA, Kramer B, Smyth CM, Wong M, Kakakios A, McCowage GB, Watson D, Alexander SI, Latham M, Cunningham SC, Zheng M, Hobson L, Rowe PB, Fischer A, Cavassana-Clavo M, Hacein-Bey_Abina S, Alexander IE. (2005) Treatment of an infant with X-linked severe Combined Immunodeficiency (SCID-X1) by gene therapy in Australia. Med. J Aust. 182 (9): 458-63.

Kramer BA, Lemckert FA, Alexander IE, Gunning PW, McCowage GB. (2006). Characterisation of a P140K mutant O(6)-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow. J Gene Med 8(9): 1071-85.

Ziegler DS, Cohn RJ, McCowage G, Alvaro F, Oswald C, Mrongovius R, White L. Australian and New Zealand Children's Study Group. Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors. Neuro-Oncology 2006; 8(1):53-9.

Ziegler DS, McCowage G, Cohn RJ, White L. Long-term survival following a phase I/II trial with VETOPEC for solid tumors in childhood. Journal of Pediatric Hematology/Oncology 2006; 28(1):40-2.

Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatric Blood & Cancer. 51(2):235-40, 2008 Aug.

Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. [Journal Article. Multicenter Study. Randomized Controlled Trial. Research Support, Non-U.S. Gov't] Pediatric Blood & Cancer. 50(6):1169-75, 2008 Jun.